Oric Pharmaceuticals (ORIC) Total Liabilities (2019 - 2026)
Oric Pharmaceuticals' (ORIC) quarterly Total Liabilities came in at $21.2 million in Q1 2026, down 8.28% YoY from $23.1 million in Q1 2025, and down 13.55% on a QoQ basis from $24.5 million in Q4 2025.
Oric Pharmaceuticals (ORIC) Total Liabilities (2019 - 2026) Analysis & Trends
Oric Pharmaceuticals (ORIC) has 8 years of Total Liabilities data on file, last reported at $21.2 million in Q1 2026.
- Quarterly Total Liabilities fell 8.28% year-over-year to $21.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.2 million (down 8.28% YoY) and the FY2025 annual result came in at $24.5 million, down 20.93% from the prior year.
- Total Liabilities slipped to $21.2 million in Q1 2026, from $24.5 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $31.0 million in Q4 2024 to a low of $21.2 million in Q1 2026.
- A 5-year average of $24.6 million and a median of $23.8 million in 2023 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2022 — Total Liabilities jumped 178.8% — and 2025, when it dropped 20.93%.
- Tracing ORIC's Total Liabilities over 5 years: stood at $24.8 million in 2022, then grew by 12.45% to $27.9 million in 2023, then rose by 11.11% to $31.0 million in 2024, then dropped by 20.93% to $24.5 million in 2025, then retreated by 13.55% to $21.2 million in 2026.
- The last three Total Liabilities figures came in at $21.2 million (Q1 2026), $24.5 million (Q4 2025), and $24.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Oric Pharmaceuticals | 1.44 Bn | 1.44 Bn | - | 23.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.43 Mn |
| Mar 31, 2026 | 21.21 Mn |
| Dec 31, 2025 | 24.53 Mn |
| Sep 30, 2025 | 24.27 Mn |
| Jun 30, 2025 | 22.86 Mn |
| Mar 31, 2025 | 23.12 Mn |
| Dec 31, 2024 | 31.02 Mn |
| Sep 30, 2024 | 28.08 Mn |
| Jun 30, 2024 | 26.51 Mn |
| Mar 31, 2024 | 22.14 Mn |
| Dec 31, 2023 | 27.92 Mn |
| Sep 30, 2023 | 26.92 Mn |
| Jun 30, 2023 | 23.02 Mn |
| Mar 31, 2023 | 23.84 Mn |
| Dec 31, 2022 | 24.83 Mn |
| Sep 30, 2022 | 23.18 Mn |
| Jun 30, 2022 | 22.81 Mn |
| Mar 31, 2022 | 21.98 Mn |
| Dec 31, 2021 | 25.67 Mn |
| Sep 30, 2021 | 22.64 Mn |